This page lists all pharmaceutical reports related to the field of Psychiatric, Addictive & Sleep Disorders. The reports include market research reports and pipeline analyses.
- Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- Smoking Cessation and Addiction Treatments: A World Market Analysis
- Alzheimer disease - new drugs, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- The World Sleep Disorders Market, 2005-2010
- The World Schizophrenia Market 2005-2010
- The World Market for Antidepressants, 2006
- Anti-addiction Therapies, 2006-2011
- Pipeline Insight: Insomnia - Targeting the sleep maintenance market
- Pipeline Insight: Depression - Novel drugs to grow third-line market
- Early Toxicology: Markets and Approaches
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Bipolar Disorder - New treatments for bipolar depression set to drive near-term growth
- Parkinson's Disease and Restless Legs Syndrome - Reformulations set to drive near-term growth
- Pipeline Insight: Schizophrenia
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need?
- Pipeline Insight: Anxiety Disorders - A decade of declining revenues
- Therapeutic Vaccines
- Pipeline and Commercial Perspectives: Insomnia
- Cognitive Impairment in Schizoaffective Disorder
- Pipeline Insight: ADHD
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Commercial Insight: Depression -Atypical lifecycle management strategy rejuvenates depression market
- Insomnia Strong brand identity critical to differentiation in an increasingly crowded market
- Irritable Bowel Syndrome - A potentially profitable market with limited competition
- Drug Discovery Tools for High-Content Analysis
- Personalized Medicine
- ANXIETY - Therapy Area Pipeline Report
- DEMENTIA - Therapy Area Pipeline Report
- DEPRESSION - Therapy Area Pipeline Report
- INSOMNIA and SLEEP DISORDERS - Therapy Area Pipeline Report
- SCHIZOPHRENIA - Therapy Area Pipeline Report
- IRRITABLE BOWEL SYNDROME (IBS) - Therapy Area Pipeline Report
- SMOKING CESSATION - Therapy Area Pipeline Report
- Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The CNS Market Outlook
- Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
- The Gastrointestinal Market Outlook to 2012
- Pipeline Insight: Orphan Diseases in CNS - Huntington's Disease
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- Pipeline Insight: Substance Dependence - Nicotine
- Adult ADHD - Therapeutic Opportunities
- Insomnia - Wake-Up Call for a Sleepy Market
- Restless Legs Syndrome - Recognition Lacking Still
- Pipeline Insight: Depression - Novel therapies key to market penetration
- Stakeholder Insight: Anxiety Disorders - More Than Just a Comorbidity
- Pipeline Insight: Antipsychotics - Novel Antipsychotics Driving Market Evolution
- Stakeholder Insight: Bipolar Disorders - Zyprexa Sets the Mood for Revenue Growth
- Commercial Insight: Antidepressants - Sliding SSRI Revenues Inevitable
- Stakeholder Insight: ADHD - Prescriber Attention Still Held by Short Acting Stimulant Drugs
- Patient Compliance in Psychiatry - From Patient Acquisition to Patient Retention
- Commercial Insight: Antipsychotics - From Blockbuster Brands to Billion Dollar Generics
- The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Innovations in CNS: Novel therapeutics and future R&D strategies
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline Insight: Substance Dependence - Alcohol
- Pipeline Insight: Substance Dependence - Part I: Nicotine
- Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
- How to Conduct Clinical Trials in China
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- CNS Market Overview - neurology, pain and psychiatry
- Neuronal Nicotinic Receptors - April 2008
- Commercial and Pipeline Insight: ADHD
